{
    "nctId": "NCT05138627",
    "briefTitle": "The Effect of Oral Cryotherapy on Anticipatory, Acute and Late Nausea and Vomiting in Breast Cancer Patients",
    "officialTitle": "The Effect of Oral Cryotherapy on Anticipatory, Acute and Late Nausea and Vomiting in Breast Cancer Patients Receiving Adjuvant Chemotherapy Treatment",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 54,
    "primaryOutcomeMeasure": "Rhodes Index of Nausea Vomiting and Retching (RINVR)",
    "eligibilityCriteria": "The inclusion criteria were as follows;\n\n* Between the ages of 18- 65\n* Open to communication and cooperation, literate\n* Knowing about their diagnosis\n* Diagnosed with breast cancer for the first time\n* Adjuvant chemotherapy protocol planned for the first time\n* Receiving AC Protocol as chemotherapy protocol\n* Who did not receive radiotherapy treatment before adjuvant chemotherapy\n* Who does not have COPD, AMI, CHF, CRF, Gastrointestinal, Neurological, Metabolic, pregnancy and non-DM\n* Who did not use a non-pharmacological method for nausea-vomiting\n* Who received standard antiemetic therapy in accordance with the AC protocol\n* Who does not have metastasis\n* Who does not have thrombocytopenia\n* Who has Stage I and Stage II breast cancer\n* Who is not treated for psychiatric and/or depression\n* Consisted of female patients who were willing and voluntarily to participate in the study.\n\nThe exclusion criteria were as follows;\n\n* Treatment delayed at least two times in a row\n* Unreachable through phone calls\n* Changed treatment regimen/drugs\n* Patients who stopped participating in the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}